IP Library Granted Patent US 11,134,872
Granted Patent B2
US 11,134,872 · App. 15/981,681 · Granted Oct 5, 2021

Thermally stable glucose limiting membrane for glucose sensors

Inventors: Jenn-Hann Larry Wang (Northridge, CA); Dero Hovanes (Glendale, CA); Poonam S. Gulati (La Canada, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61B5/14865A61B5/14532A61B5/686C08G18/3228C08G18/4009C08G18/44C08G18/5024C08G18/61C08G18/72C08G18/724C08G18/73C08G18/7671C08L75/12A61B5/6876A61B2562/125C08G77/448C08G77/458
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,134,872
App. No.
15/981,681
Granted
Oct 5, 2021
Kind
B2
Abstract

Embodiments of the invention provide compositions useful in analyte sensors as well as methods for making and using such compositions and sensors. In typical embodiments of the invention, the sensor is a glucose sensor comprising an analyte modulating membrane formed from a polymeric reaction mixture formed to include limiting amounts of catalyst and/or polycarbonate compounds so as to provide such membranes with improved material properties such as enhanced thermal and hydrolytic stability.

Claims (22)

1. A method of increasing the thermal stability of a biocompatible membrane formed by a reaction mixture comprising:

a diisocyanate;

a hydrophilic polymer comprising a hydrophilic diol or hydrophilic diamine;

a siloxane having an amino, hydroxyl or carboxylic acid functional group at a terminus;

a polycarbonate diol; and

a catalyst;

the method comprising forming the reaction mixture such that the catalyst is present in the reaction mixture in amounts less than 0.2% of reaction mixture components;

thereby increasing the thermal stability of the biocompatible membrane as compared to a comparable membrane formed from a reaction mixture where the catalyst is present in the reaction mixture in amounts greater than or equal to 0.2% of the reaction mixture; wherein:

the biocompatible membrane comprises:

from 17% to 23% weight percent hexamethylene diisocyanate;

from 0% to 8.5% weight percent methylene diphenyl diisocyanate;

from 14% to 48% weight percent polydimethylsiloxane having amino terminal groups; and

from 7.5% to 19% weight percent poly(1,6-hexyl carbonate) diol.

2. The method of claim 1 , wherein the catalyst is present in the reaction mixture in amounts less than 0.11% of the reaction mixture.

3. The method of claim 1 , wherein:

(a) the biocompatible membrane comprises:

about 22% hexamethylene diisocyanate; and

about 3.5% methylene diphenyl diisocyanate;

(b) the biocompatible membrane comprises about 22.5% polydimethylsiloxane having amino terminal groups; and

(c) the biocompatible membrane comprises about 7.5% poly(1,6-hexyl carbonate) diol.

4. The method of claim 1 , wherein water is added as a chain extender in the reaction mixture.

5. The method of claim 1 , wherein thermal stability of the biocompatible membrane is measured by observing changes in molecular weight of the biocompatible membrane maintained at a temperature of 60° C. over at least 3, 5 or 7 days.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2019
From: WANG, JENN-HANN LARRY; HOVANES, DERO; GULATI, POONAM S.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 051196/0088 →
Continuity (3)
Continuation In Part 15612759 · Jun 2, 2017
Provisional Application 62346301 · Jun 6, 2016
Related Publication 20180325436A1 · Nov 15, 2018
Cited By (1)
US 12,366,548